Phase I study of abagovomab in patients with epithelial ovarian, fallopian tube, or primary peritoneal cancer. uri icon

Overview

publication date

  • July 1, 2007

Research

keywords

  • Antibodies, Anti-Idiotypic
  • Fallopian Tube Neoplasms
  • Ovarian Neoplasms
  • Peritoneal Neoplasms

Identity

Scopus Document Identifier

  • 34447117547

Digital Object Identifier (DOI)

  • 10.1158/1078-0432.CCR-06-2664

PubMed ID

  • 17606738

Additional Document Info

volume

  • 13

issue

  • 13